The total number of records retrieved from this search are 6. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1252	Virus nameVesicular stomatitis virus	Virus strainwild type	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationYes	Virus aloneNo	Virus in combination with drug/radiationVSV in combination with cisplatin (0.1 microgram/ml)	Immune gene insertion in viral genomeVirus expressing IL-12 gene	Source of cell lineGibco	Origin of cell lineHuman keratinocyte	Cell lineHuK	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro result20% cancer cell killing after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18043494
IDOV_1253	Virus nameVesicular stomatitis virus	Virus strainwild type	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationYes	Virus aloneNo	Virus in combination with drug/radiationVSV in combination with cisplatin (0.1 microgram/ml)	Immune gene insertion in viral genomeVirus expressing IL-12 gene	Source of cell lineGibco	Origin of cell lineHuman keratinocyte	Cell lineHuK	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro result20% cancer cell killing after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18043494
IDOV_1254	Virus nameVesicular stomatitis virus	Virus strainwild type	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationYes	Virus aloneNo	Virus in combination with drug/radiationVSV in combination with cisplatin (0.1 microgram/ml)	Immune gene insertion in viral genomeVirus expressing IL-12 gene	Source of cell lineGibco	Origin of cell lineHuman keratinocyte	Cell lineHuK	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro result20% cancer cell killing after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18043494
IDOV_1255	Virus nameVesicular stomatitis virus	Virus strainFusogenic strain	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationYes , expressing fusion protein	Virus aloneNo	Virus in combination with drug/radiationVSV in combination with cisplatin (0.1 microgram/ml)	Immune gene insertion in viral genomeNo	Source of cell lineGibco	Origin of cell lineHuman keratinocyte	Cell lineHuK	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro resultNo cell killing after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18043494
IDOV_1256	Virus nameVesicular stomatitis virus	Virus strainFusogenic strain	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationYes , expressing fusion protein	Virus aloneNo	Virus in combination with drug/radiationVSV in combination with cisplatin (0.1 microgram/ml)	Immune gene insertion in viral genomeNo	Source of cell lineGibco	Origin of cell lineHuman keratinocyte	Cell lineHuK	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro resultNo cell killing after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18043494
IDOV_1257	Virus nameVesicular stomatitis virus	Virus strainFusogenic strain	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationYes , expressing fusion protein	Virus aloneNo	Virus in combination with drug/radiationVSV in combination with cisplatin (0.1 microgram/ml)	Immune gene insertion in viral genomeNo	Source of cell lineGibco	Origin of cell lineHuman keratinocyte	Cell lineHuK	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro resultNo cell killing after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18043494